Skip to main content
SpringerLink
Log in

Prevalence and treatment of breathing disorders during sleep in patients with heart failure

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Heart failure is a highly prevalent disorder, with significant economic impact, and is associated with excess morbidity and mortality. One factor that may contribute to the progressively declining course of heart failure is the occurrence of recurrent episodes of apnea and hypopnea. There are two major kinds of sleep-related breathing disorders: obstructive and central sleep apnea. In patients with heart failure, in contrast to the general population, central sleep apnea is the most common form of sleep-related breathing disorder. Episodes of apnea, hypopnea, and the subsequent hyperpnea cause sleep disruption, arousals, hypoxemia-reoxygenation, hypercapnia/hypocapnia, and changes in intrathoracic pressure. These pathophysiologic consequences of sleep-related breathing disorders have deleterious effects on the cardiovascular system, and may be even more pronounced in the setting of established heart failure and coronary artery disease. Therefore, sleep apnea in heart failure should be treated. Central sleep apnea may be treated with nocturnal supplemental nasal oxygen, theophylline, or nasal-positive pressure devices, such as nasal continuous positive airway pressure (CPAP). The treatment of choice for obstructive sleep apnea is nasal CPAP. Although long-term controlled trials of the effect of treatment of sleep apnea on mortality in patients with heart failure are still pending, treatment of sleep apnea, both obstructive and central, does result in a decrease in sympathetic activity and an improvement in systolic function, which are known surrogates of mortality. Therefore, diagnosis and treatment of sleep-related breathing disorders may increase survival of patients with heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Javaheri S: Sleep-related breathing disorders in heart failure. In Heart Failure, A Companion to Braunwald’s Heart Disease. Edited by Mann DL. Philadelphia: WB Saunders; 2004:471–487. Reviews cardiovascular consequences of sleep apnea in heart failure.

    Google Scholar 

  2. Javaheri S: Heart failure. In Principles and Practice of Sleep Medicine, edn 4. Edited by Kryger MH, et al. Philadelphia: WB Saunders; 2005:1208–1217. The most updated article regarding sleep-related breathing disorders in heart failure.

    Google Scholar 

  3. Javaheri S, ParkerTJ, Wexler L, et al.: Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995, 122:487–492. [Published erratum appears in Ann Intern Med 1995, 123:77.]

    PubMed  CAS  Google Scholar 

  4. Javaheri S, Parker TJ, Liming JD, et al.: Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998, 97:2154–2159.

    PubMed  CAS  Google Scholar 

  5. Somers VK, Dyken ME, Mark AL, et al.: Sympatheticnerve activity during sleep in normal subjects. N Engl J Med 1993, 328:303–307.

    Article  PubMed  CAS  Google Scholar 

  6. Fletcher EC, Proctor M, Yu J, et al.: Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med 1999, 160:1688–1696.

    PubMed  CAS  Google Scholar 

  7. Hanly PJ, Millar TW, Steljes DG, et al.: Respiration and abnormal sleep in patients with congestive heart failure. Chest 1989, 96:480–488.

    PubMed  CAS  Google Scholar 

  8. Lofaso F, Verschueren P, Rande JLD, et al.: Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 1994, 106:1689–1694.

    PubMed  CAS  Google Scholar 

  9. Sin DD, Fitzgerald F, Parker JD, et al.: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160:1101–1106.

    PubMed  CAS  Google Scholar 

  10. Solin P, Bergin P, Richardson M, et al.: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999, 99:1574–1579.

    PubMed  CAS  Google Scholar 

  11. Tremel F, Pépin JL, Veale D, et al.: High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999, 20:1201–1209.

    Article  PubMed  CAS  Google Scholar 

  12. Fries R, Bauer D, Heisel A, et al.: Clinical significance of sleep-related breathing disorders in patients with implantable cardioverter deflbrillators. Pace 1999, 22:223–227.

    PubMed  CAS  Google Scholar 

  13. Lanfranchi PA, Braghiroli A Bosimini E, et al.: Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999, 99:1435–1440.

    PubMed  CAS  Google Scholar 

  14. Javaheri S: Central sleep apnea in congestive heart failure: prevalence, mechanisms, impact, and therapeutic options. Semin Respir Crit Care Med 2005, 26:44–55.

    Article  PubMed  Google Scholar 

  15. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep disordered breathing among middle aged adults. N Engl J Med 1993, 328:1230–1235.

    Article  PubMed  CAS  Google Scholar 

  16. Chan J, Sanderson J, Chan W, et al.: Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997, 111:1488–1493.

    PubMed  CAS  Google Scholar 

  17. Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:1217–1239.

    Article  PubMed  Google Scholar 

  18. Mooe T, Franklin KA, Holmstrom K, et al.: Sleep-disordered breathing and coronary artery disease: longterm prognosis. Am J Respir Crit Care Med 2001, 164:1910–1913.

    PubMed  CAS  Google Scholar 

  19. Peker Y, Hedner J, Kraiczi H, et al.: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000, 162:81–86. Showed that obstructive sleep apnea increases the mortality in patients with established coronary artery disease.

    PubMed  CAS  Google Scholar 

  20. Findley LJ, Zwillich CW, Ancoli-Israel S, et al.: Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 1985, 78:11–15.

    PubMed  CAS  Google Scholar 

  21. Hanly P, Zuberi-Khkhar N: Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996, 153:272–276.

    PubMed  CAS  Google Scholar 

  22. Ancoli-Israel S, DuHamel ER, Stepnowsky C, et al.: The relationship between congestive heart failure, sleep apnea and mortality in older men. Chest 2003, 124:1400–1405.

    Article  PubMed  Google Scholar 

  23. Sin DD, Logan AG, Fitzgerald FS, et al.: Effects of continuous positive airway pressure on cardiovascular out-comes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000, 102:61–66. This report of a small number of patients with systolic heart failure showed that patients with central sleep apnea have a higher mortality than patients without central sleep apnea, and treatment of central sleep apnea with the CPAP device improves survival.

    PubMed  CAS  Google Scholar 

  24. Leite JJ, Mansur AJ, de Freitas HFG, et al.: Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. J Am Coll Cardiol 2003, 41:2175–2181.

    Article  PubMed  Google Scholar 

  25. Andreas S, Hagenah G, Möller C, et al.: Cheyne-Stokes respiration and prognosis in congestive heart failure. Am] Cardiol 1996, 78:1260–1264.

    Article  CAS  Google Scholar 

  26. Roebuck T, Solin P, Kaye DM et al.: Increased long term mortality in heart failure due to sleep apnea is not yet proven. European Respir J 2004, 23:735–740.

    Article  CAS  Google Scholar 

  27. Javaheri S: Prevalence and prognostic significance of sleep apnea in heart failure. In Sleep Apnea. Implications in Cardiovascular and Cerebrovascular Disease. Edited by Bradley TD, Floras JS. New York, NY: Marcel Dekker; 2000:415–433.

    Google Scholar 

  28. Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 248:1233–1241. This is a small study of 24 patients with systolic heart failure and obstructive sleep apnea randomized to a control group versus CPAP therapy. It showed that the use of this device improves left ventricular ejection fraction.

    Article  Google Scholar 

  29. MansfieldDR, Gollogly C, Kaye DM: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169:361–366. This study of a large number of patients with obstructive sleep apnea confirmed the results of Kaneko et al. [28].

    Article  PubMed  Google Scholar 

  30. Javaheri S: Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000, 101:392–397. Showed that use of CPAP device in patients with systolic heart failure and central sleep apnea decreases the number of nocturnal ventricular arrhythmias when central sleep apnea improves with use of the device.

    PubMed  CAS  Google Scholar 

  31. Naughton MT, Bernard DC, Liu PR et al.: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995, 152:473–479.

    PubMed  CAS  Google Scholar 

  32. Staniforth AD, Kinneart WJM, Hetmanski DJ, et al.: Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998, 19:922–928.

    Article  PubMed  CAS  Google Scholar 

  33. Andreas S, Bingeli C, Mohacsi P, et al.: Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest 2003, 123:366–371. This study confirms the results of Staniforth et al. [32] using peroneal nerve sympathetic activity.

    Article  PubMed  Google Scholar 

  34. Andreas S, Clemens C, Sandholzer H, et al.: Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996, 27:1486–1490.

    Article  PubMed  CAS  Google Scholar 

  35. Hudgel D, Chapman KR, Franks C, et al.: Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxemia during sleep. Am Rev Respir Dis 1987, 135:899–906.

    PubMed  CAS  Google Scholar 

  36. Shepard JW, Pevernagie DA, Stanson AW, et al.: Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996, 153:250–254.

    PubMed  Google Scholar 

  37. Calle EE, Thun MJ, Petrelli JM, et al.: Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999, 341:1097–1105.

    Article  PubMed  CAS  Google Scholar 

  38. Kenchaiah S, Evans JC, Levy D, et al.: Obesity and the risk of heart failure. N Engl J Med 2002, 347:305–313.

    Article  PubMed  Google Scholar 

  39. JavaheriS: Pembrey’s Dream: the time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. Chest 2003, 123:322–325. This editorial emphasized the need for long-term doubleblind, placebo-controlled studies to determine if use of nocturnal oxygen improves mortality of patients with systolic heart failure and central sleep apnea.

    Article  PubMed  Google Scholar 

  40. Dowdell WT, Javaheri S, McGinnis W: Cheyne-Stokes respiration presenting as sleep apnea syndrome. Clinical and polysomnographic features. Am Rev Respir Dis 1990, 141:871–879.

    PubMed  CAS  Google Scholar 

  41. Arendt J, Bojkowski C, Franey C, et al.: Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 1985, 60:1166–1173.

    Article  PubMed  CAS  Google Scholar 

  42. Stoschitzky K, Sakotnik A, Lercher P, et al.: Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999, 55:111–115.

    Article  PubMed  CAS  Google Scholar 

  43. Javaheri S, Abraham W, Brown C, et al.: Prevalence of obstructive sleep apnea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 2004, 25:260–266. This is the largest and most systematic study showing occurrence of obstructive sleep apnea and periodic limb movement in cardiac transplant recipients.

    Article  PubMed  Google Scholar 

  44. Javaheri S: Heart failure and sleep apnea: emphasis on practical therapeutic options. Clin Chest Med 2003, 24:207–222. A review article regarding use of positive pressure airway devices in patients with heart failure and various types of sleep apnea.

    Article  PubMed  Google Scholar 

  45. Keily JL, Deegan P, Buckley A, et al.: Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm. Thorax 1998, 53:956–962.

    Google Scholar 

  46. Guilleminault C, Clerk A Labanowski M, et al.: Cardiac failure and benzodiazepines. Sleep 1993, 16:524–528.

    PubMed  CAS  Google Scholar 

  47. Davies RJO, Harrington KJ, Ormerod JM, et al.: Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing. Am Rev Respir Dis 1993, 147:630–634.

    PubMed  CAS  Google Scholar 

  48. Buckle P, Millar T, Kryger M: The effects of short-term nasal CPAP on Cheyne-Stokes respiration in congestive heart failure. Chest 1992, 102:31–35.

    PubMed  CAS  Google Scholar 

  49. Teschler H, Döhring J, Wang YM, Berthon-Jones M: Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 64:614–619.

    Google Scholar 

  50. Garrigue S, Bordier P, Jais P, et al.: Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002, 346:404–412.

    Article  PubMed  Google Scholar 

  51. Abraham WT, Hayes DL: Cardiac resynchronization therapy for heart failure. Circulation 2004, 108:2596–2603.

    Article  Google Scholar 

  52. Javaheri S, Parker TJ, Wexler L, et al.: Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996, 335:562–567.

    Article  PubMed  CAS  Google Scholar 

  53. Hanly PF, Millar TW, Steljes DG, et al.: The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989, 111:777–782.

    PubMed  CAS  Google Scholar 

  54. Javaheri S, Ahmed M, Parker TJ, Brown CR: Effects of nasal O2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999, 22:1101–1106.

    PubMed  CAS  Google Scholar 

  55. Javaheri S, Teppama LJ, Evers JAM: Effects of aminophylline on hypoxemia-induced ventilatory depression in cats. J Appl Physiol 1988, 64:1837–1843.

    PubMed  CAS  Google Scholar 

  56. Javaheri S, Evers JAM, Teppema LJ: Increase in ventilation caused by aminophylline in the absence of changes in ventral extracellular fluid pH and PCO2. Thorax 1989, 44:121–125.

    Article  PubMed  CAS  Google Scholar 

  57. Javaheri S, Guerra LF: Lung function, hypoxic and hypercapnic ventilatory responses, and respiratory muscle strength in normal subjects taking oral theophylline. Thorax 1990, 45:743–747.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VA Medical Center, Department of Medicine, University of Cincinnati College of Medicine, 3200 Vine Street, 45220, Cincinnati, OH, USA

    Shahrokh Javaheri MD

Authors
  1. Shahrokh Javaheri MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Wexler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Javaheri, S., Wexler, L. Prevalence and treatment of breathing disorders during sleep in patients with heart failure. Curr Treat Options Cardio Med 7, 295–306 (2005). https://doi.org/10.1007/s11936-005-0040-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-005-0040-0

Keywords

Search

Navigation